Our study demonstrated that treatment with Ad-ANGPTL4 significantly suppressed not only the in vivo growth, angiogenesis and invasiveness, but also the extrahepatic multiorgan metastases of HCC. The gene discussed is ANGPTL4; the disease is hepatocellular carcinoma.